Real-time enrollment status for this graft-versus-host disease clinical trial
Current Status
Completed
Checked: June 1, 2026 at 7:38 PM UTC
| NCT Number | NCT03805789 |
| Recruiting Status | Completed |
| Condition | Graft-versus-host Disease |
| Phase | Clinical Trial |
| Target Enrollment | 310 participants |
| Active Locations | 12 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of June 1, 2026: Clinical trial NCT03805789 is currently completed participants. This clinical trial study for graft-versus-host disease is not currently accepting new participants at 12 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03805789 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03805789 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.